Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
52,237,407
-
Share change
-
+36,502,102
-
Total reported value
-
$3,252,514,720
-
Put/Call ratio
-
256%
-
Price per share
-
$62.25
-
Number of holders
-
194
-
Value change
-
+$2,244,308,382
-
Number of buys
-
181
-
Number of sells
-
42
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2015
As of 30 Sep 2015,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
194 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,237,407 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, JPMORGAN CHASE & CO, UBS Group AG, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, CREDIT SUISSE AG/, BANK OF AMERICA CORP /DE/, SG Americas Securities, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
194
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.